ML21099A105

Request for Withholding Information from Public Disclosure

ML21099A105
Person / Time
Site:	Turkey Point
Issue date:	04/23/2021
From:	Ellen Brown Plant Licensing Branch II
To:	Moul D Florida Power & Light Co
Brown E
References
EPID L-2021-LRM-0007
Download: ML21099A105 (3)

Text

April 23, 2021 Mr. Don Moul Vice President, Nuclear Division and Chief Nuclear Officer Florida Power & Light Company Mail Stop: NT3/JW 15430 Endeavor Drive Jupiter, FL 33478

SUBJECT:

TURKEY POINT NUCLEAR GENERATING UNIT NOS. 3 AND 4 - REQUEST FOR WITHHOLDING INFORMATION FROM PUBLIC DISCLOSURE (EPID L-2021-LRM-0007)

Dear Mr. Moul:

Florida Power and Light submitted an affidavit dated April 5, 2021, executed by Philip Opsal of Framatome Inc., requesting that the information contained in the slide presentation entitled Turkey Point Unit 3 and Unit 4, Reactor Protection System, Engineered Safety Feature Actuation System, Nuclear Instrumentation System Replacements, Safety System Replacement Project LAR, NRC 4th Pre-submittal Meeting Telecon, April 8, 2021, Closed Session, be withheld from public disclosure pursuant to Section 2.390 of Title 10 of the Code of Federal Regulations (10 CFR). A nonproprietary copy of this document has been placed in the U.S.

Nuclear Regulatory Commissions (NRC) Public Document Room and added to the NRC Library in the Agencywide Documents Access and Management System (ADAMS).

The affidavit stated that the submitted information should be considered exempt from mandatory public disclosure for the following reasons:

(b)

Use of the information by a competitor would permit the competitor to significantly reduce its expenditures, in time or resources, to design, produce, or market a similar product or service; (d)

The information reveals certain distinguishing aspects of a process, methodology, or component, the exclusive use of which provides a competitive advantage for Framatome in product optimization or marketability; and (e)

The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.

We have reviewed your applications and the material in accordance with the requirements of 10 CFR 2.390 and, on the basis of the statements in the affidavit, have determined that the submitted information sought to be withheld contains proprietary commercial information and should be withheld from public disclosure.

Therefore, the version of the submitted information marked as proprietary will be withheld from public disclosure pursuant to 10 CFR 2.390(b)(5) and Section 103(b) of the Atomic Energy Act of 1954, as amended.

Withholding from public inspection shall not affect the right, if any, of persons properly and directly concerned to inspect the documents. If the need arises, we may send copies of this information to our consultants working in this area. We will, of course, ensure that the consultants have signed the appropriate agreements for handling proprietary information.

If the basis for withholding this information from public inspection should change in the future such that the information could then be made available for public inspection, you should promptly notify the NRC. You also should understand that the NRC may have cause to review this determination in the future, for example, if the scope of a Freedom of Information Act request includes your information. In all review situations, if the NRC makes a determination adverse to the above, you will be notified in advance of any public disclosure.

If you have any questions regarding this matter, I may be reached at 301-415-2315.

Sincerely,

/RA/

Eva A. Brown, Senior Project Manager Plant Licensing Branch II-2 Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket Nos.: 50-250 and 50-251 cc:

Listserv Framatome Inc.

Attention: Philip Opsal 3315 Old Forest Road Lynchburg, VA 24501 Philip.Opsal@framatome.com

ML21099A105

• via e-mail OFFICE NRR/DORL/LPL2-2/PM*

NRR/DORL/LPL2-2/LA*

NRR/DORL/LPL2-2/BC*

NAME EBrown RButler DWrona DATE 04/09/2021 04/12/2021 04/23/2021